// App-Quantinova.ai

POS1412 (2021) : IDENTIFYING HIGH-COST DRUGS FOR RARE RHEUMATIC DISEASES IN ROUTINELY COLLECTED NHS DATA. RESULTS FROM A PILOT STUDY OF RITUXIMAB USE IN VASCULITIS USING DATA FROM THE NATIONAL DISEASE REGISTRATION SERVICE AND THE REGISTRATION OF COMPLEX RARE DISEASES-EXEMPLARS IN RHEUMATOLOGY (RECORDER) PROJECT

Researchers

Presenter

  • C. Godsave

Principal Investigators

  • M. Chakravorty

  • M. Rutter

  • P. Lanyon

  • J. Aston

  • S. Stevens

  • F. Pearce

Medical Centers

  • Royal Derby Hospital, Rheumatology, Derby, United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • University of Nottingham, Division of Epidemiology and Public Health, Nottingham, United Kingdom

  • Public Health England, National Congenital Anomaly and Rare Disease Registration Service, London, United Kingdom

  • National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Eosinophilic granulomatosis with polyangiitis

  • Microscopic polyangiitis

  • Polyarteritis nodosa

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved